These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37616532)

  • 61. Detection of psychological distress in patients with psoriasis: low consensus between dermatologist and patient.
    Richards HL; Fortune DG; Weidmann A; Sweeney SK; Griffiths CE
    Br J Dermatol; 2004 Dec; 151(6):1227-33. PubMed ID: 15606519
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Intralesional methotrexate in dermatology: Diverse indications and practical considerations.
    Searle T; Ali FR; Al-Niaimi F
    Dermatol Ther; 2021 Jan; 34(1):e14404. PubMed ID: 33044042
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Dermatologists' views and opinions about photo(chemo)therapy and conventional systemic psoriasis therapies: results from a Belgian survey.
    Nijsten T; Lambert J
    Dermatology; 2006; 213(2):123-33. PubMed ID: 16902289
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Systemic treatment of severe psoriasis.
    Georgouras KE; Zagarella SS; Cains GD; Brown PJ
    Australas J Dermatol; 1997 Nov; 38(4):171-80; quiz 181-2. PubMed ID: 9431708
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The effect of folate supplementation on methotrexate efficacy and toxicity in psoriasis patients and folic acid use by dermatologists in the USA.
    Al-Dabagh A; Davis SA; Kinney MA; Huang K; Feldman SR
    Am J Clin Dermatol; 2013 Jun; 14(3):155-61. PubMed ID: 23575550
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Methotrexate and cyclosporine in psoriasis revisited.
    Strober BE
    Semin Cutan Med Surg; 2014 Mar; 33(2 Suppl 2):S27-30. PubMed ID: 24979542
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Current systemic therapies for psoriasis: where are we now?
    Yamauchi PS; Rizk D; Kormeili T; Patnaik R; Lowe NJ
    J Am Acad Dermatol; 2003 Aug; 49(2 Suppl):S66-77. PubMed ID: 12894129
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pulmonary complications following methotrexate therapy.
    Phillips TJ; Jones DH; Baker H
    J Am Acad Dermatol; 1987 Feb; 16(2 Pt 1):373-5. PubMed ID: 3819074
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Comparison of the Efficacy of Methotrexate and Narrow-Band Ultraviolet B for the Treatment of Plaque-Type Psoriasis.
    Solak B; Dikicier BS; Yaldz M; Erkorkmaz U; Erdem T
    Am J Ther; 2016; 23(2):e405-10. PubMed ID: 25470611
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Enhanced liver fibrosis test in patients with psoriasis, psoriatic arthritis and rheumatoid arthritis: a cross-sectional comparison with procollagen-3 N-terminal peptide (P3NP).
    van der Voort EAM; Wakkee M; Veldt-Kok P; Darwish Murad S; Nijsten T
    Br J Dermatol; 2017 Jun; 176(6):1599-1606. PubMed ID: 27925155
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Elevated serum aminoterminal procollagen type III peptide in methotrexate-induced hepatic fibrosis.
    Fairris GM; Brooks B; Tanner A
    Br J Dermatol; 1986 Apr; 114(4):520-1. PubMed ID: 3964554
    [No Abstract]   [Full Text] [Related]  

  • 72. Infliximab is associated with an increased risk of serious infection in patients with psoriasis in the U.K. and Republic of Ireland: results from the British Association of Dermatologists Biologic Interventions Register (BADBIR).
    Yiu ZZN; Ashcroft DM; Evans I; McElhone K; Lunt M; Smith CH; Walton S; Murphy R; Reynolds NJ; Ormerod AD; Griffiths CEM; Warren RB;
    Br J Dermatol; 2019 Feb; 180(2):329-337. PubMed ID: 30070708
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Pharmacogenetic markers to predict the clinical response to methotrexate in south Indian Tamil patients with psoriasis.
    Indhumathi S; Rajappa M; Chandrashekar L; Ananthanarayanan PH; Thappa DM; Negi VS
    Eur J Clin Pharmacol; 2017 Aug; 73(8):965-971. PubMed ID: 28444425
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Rapid and sustained improvement in bone and cartilage turnover markers with the anti-interleukin-6 receptor inhibitor tocilizumab plus methotrexate in rheumatoid arthritis patients with an inadequate response to methotrexate: results from a substudy of the multicenter double-blind, placebo-controlled trial of tocilizumab in inadequate responders to methotrexate alone.
    Garnero P; Thompson E; Woodworth T; Smolen JS
    Arthritis Rheum; 2010 Jan; 62(1):33-43. PubMed ID: 20039425
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Use of conventional systemic treatments in psoriasis: systematic review and expert opinion of a panel of dermatologists.
    Paul C; Ortonne JP
    J Eur Acad Dermatol Venereol; 2011 May; 25 Suppl 2():1. PubMed ID: 21388452
    [No Abstract]   [Full Text] [Related]  

  • 76. Risk-benefit assessment of methotrexate in the treatment of severe psoriasis.
    Kuijpers AL; van de Kerkhof PC
    Am J Clin Dermatol; 2000; 1(1):27-39. PubMed ID: 11702302
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Serum type III procollagen in children with type I hereditary tyrosinemia.
    Pitkänen S; Salo MK; Vettenranta K; Näntö-Salonen K; Heikinheimo M
    J Pediatr Gastroenterol Nutr; 1999 Jul; 29(1):38-41. PubMed ID: 10400101
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Methotrexate and psoriasis: 2009 National Psoriasis Foundation Consensus Conference.
    Kalb RE; Strober B; Weinstein G; Lebwohl M
    J Am Acad Dermatol; 2009 May; 60(5):824-37. PubMed ID: 19389524
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Psoriasis treatment in the United States at the end of the 20th century.
    Pearce DJ; Stealey KH; Balkrishnan R; Fleischer AB; Feldman SR
    Int J Dermatol; 2006 Apr; 45(4):370-4. PubMed ID: 16650160
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Outcomes of methotrexate therapy for psoriasis and relationship to genetic polymorphisms.
    Warren RB; Smith RL; Campalani E; Eyre S; Smith CH; Barker JN; Worthington J; Griffiths CE
    Br J Dermatol; 2009 Feb; 160(2):438-41. PubMed ID: 19016697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.